Antonella Carbone

Professionista esperto nella gestione organizzativa e nella motivazione del personale al raggiungimento degli obiettivi. Dotata di capacità comunicative e negoziali, è alla costante ricerca di soluzioni innovative al fine del raggiungimento degli obiettivi prefissati.

• Excellent RAI therapeutic response on a patient presenting skull metastasis of follicular thyroid cancer after 15 years.

Carbone A, Verrienti A, Cito DS, Corazza C, Bruno R.Endocrine. 2025 Feb;87(2):468-473. doi: 10.1007/s12020-024-04036-3. Epub 2024 Sep 18.PMID: 39294518

• Effective TRIAC treatment of a THRbeta-mutated patient with thyroid hormone resistance.

Carbone A, Verrienti A, Cito DS, Sponziello M, Pecce V, Bruno R.Endocrine. 2024 Aug;85(2):598-600. doi: 10.1007/s12020-024-03795-3. Epub 2024 Apr 1.PMID: 38558372

• Prospective Validation of ATA Risk Score for Papillary Thyroid Microcarcinoma: An ITCO Real-World Study.

De Leo S, Brigante G, D'Elia S, Censi S, Madeo B, Morelli S, Nervo A, Repaci A, Sparano C, Stramazzo I, Virili C, Bertagna F, Dondi F, Puxeddu E, Talpacci E, Zatelli MC, Ambrosio MR, Felicetti F, Piovesan A, Petrone L, Adornato V, Trevisan M, Fugazzola L, Mele C, Zavattaro M, Solaroli E, Salituro N, Rossi M, Pagano L, Colapinto A, Basso C, Ceresini G, Marina M, Crocetti U, Massa M, Deandrea M, Retta F, Spiazzi G, Rolli N, Bruno R, Carbone A, Rotondi M, Magri F, Fallahi P, Chiofalo MG, Santaguida MG, Monti S, Porcelli T, Castello R, Sagnella A, Clausi C, Di Dalmazi G, Tumino D, Palermo A, Brunetti A, Lania A, Liverani A, Durante C, Petrillo UF, Alfo' M, Filetti S, Grani G.J Clin Endocrinol Metab. 2025 Nov 18;110(12):e4196-e4204. doi: 10.1210/clinem/dgaf190.PMID: 40165363

• CiteData-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk ThyroidCancer Follow-up: ITCO Real-world Analysis.Grani G, D'Elia S, Puxeddu E, Morelli S, Arvat E, Nervo A, Spiazzi G, Rolli N, Zatelli MC, Ambrosio MR, Ceresini G, Marina M, Mele C, Aimaretti G, Santaguida MG, Virili C, Crescenzi A, Palermo A, Rossetto Giaccherino R, Meomartino L, Castagna MG, Maino F, Trevisan M, De Leo S, Chiofalo MG, Pezzullo L, Sparano C, Petrone L, Di Dalmazi G, Napolitano G, Tumino D, Crocetti U, Bertagna F, Deandrea M, Antonelli A, Mian C, Carbone A, Monti S, Porcelli T, Brigante G, Barbaro D, Alfò M, Ferraro Petrillo U, Filetti S, Durante C.J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1377-e1384. doi: 10.1210/clinem/dgae559.PMID: 39150986
• Verrienti A, Carbone A, Sponziello M, Pecce V, Cito DS, Bruno R. Papillary thyroid carcinoma as first and isolated neoplastic disease in a Lynch syndrome family member with a germline MLH1 mutation. Endocrine. 2022 Jun;77(1):199-202. doi: 10.1007/s12020-022-03048-1. Epub 2022 Apr 12. PMID: 35415788.
• Verrienti A, Carbone A, Cito DS, Sponziello M, Pecce V, Bruno R. Long-term disease recurrence in the adipose tissue and striated muscles of a minimally invasive papillary thyroid carcinoma. Endocrine. 2021 Jun;72(3):937-939. doi: 10.1007/s12020-020-02558-0. Epub 2020 Dec 4. PMID: 33275186.
• Mediastinal lymph node metastases 6 years after latero-cervical lymph node dissection for metastases from undiagnosed occult papillary thyroid carcinoma. Antonella Carbone, Domenico Savio Cito, Pasquale Bellitti, Maria Chiara Fabiano and Rocco Bruno Endocrine Jul 2020.
• Desmoid tumor after total thyroidectomy and radioiodine therapy for papillary thyroid carcinoma. Antonella Carbone, Domenico Savio Cito, Pasquale Bellitti, Maria Chiara Fabiano and Rocco Bruno. International Journal of Medical Science and Health Research , vol 3, no.06 2019.
• Papillary thyroid microcarcinoma: active surveillance in the follow-up of persistence structural disease. Pasquale Bellitti, Antonella Carbone, Domenico Savio Cito, Rocco Bruno. Haematology and Medical Oncology 2018 vol.3(2):1-1.
• Papillary carcinoma in struma ovarii Carbone A, Lagoni Gro G., Bruno R., Journal Endocrinol Investigation June 2017, Volume 40, issue 6, pp 687–688.
• Genotype-Phenotype correlation in a MODY2 family: an under-diagnosed disease. Fabiano M.C., Verrienti A., Carbone A., Sponziello M., Bellitti P., Bruno R. Journal of Diabetes Mellitus, 2016,6, 263-268.
• A novel double mutation val 648ile and val804leu of RET protooncogene in multiple endocrine neoplasia type2. Verrienti A., Carbone A., Bellitti P., Fabiano M.C., De Rose RF, Maranghi M., Lucia P., Durante C., Rosignolo F., Pecce V., Sponziello M., Puppin C., Costante G., Bruno R. Endocrine Pract.2015 Nov; 21(11): 1248-54.
• Hashimoto’s encefalopathy (HE): an underdiagnosed autoimmune-mediated encephalopathy. Carbone A., Amenduni T., Bruno R. Endocrine 2015 Dec9, DOI:10.1007/s12020-015-0806-4
• Precocious and isolated thyroid metastasis of colorectal adenocarcinoma and incidental thyroid papillary microcarcinoma. Amenduni T., Carbone A., Bruno R. Endocrine.2014 Dec; 47(3): 969-970.
• Lymph node metastasis from undiagnosed occult papillary thyroid cancer. Carbone A., Bellitti P., Bruno R. Endocrine,2014 apr 45(3):504-5.
• A case of anaplastic diffuse large B-cell thyroid lymphoma: unique immunophenotype and unusual clinical presentation. Bruno R., Giannasio P., Bellitti P., Carbone A., Poggiaspalla M., Russo D., Costante G. J Endocrinol Investi 2010, Nov 33(10):767-8.
• Unusual association of Hashimoto's thyroiditis autoimmune hepatitis. Amenduni T., Bellitti P., Carbone A., De Sanctis D., Santospirito EV, Colucci R, Minnaja G., Bruno R. Thyroid,2007 Dec; 17(12):1307-8.
• Human thyrotropin reduces serum vascular endothelial growth factor levels in patients monitored for thyroid carcinoma even in the absence of thyroid tissue. Sorvillo F, Mazziotti G, Carbone A, Piscopo M, Rotondi M, Cioffi M, Musto P, Biondi B, Iorio S, Amato G, Carella C. J Clin Endocrinol Metab. 2003 Oct;88(10):4818-22.
• Grey-scale analysis allows a quantitative evaluation of thyroid echogenicity patients with Hashimoto's thyroiditis. Mazziotti G, Sorvillo F, Iorio S, Carbone A, Romeo A, Piscopo M, Capuano S, Capuano E, Amato G, Carella C Clin Endocrinol (Oxf). 2003 Aug;59(2):223-9.
• Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis. Sorvillo F, Mazziotti G, Carbone A, Morisco F, Cioffi M, Rotondi M, Stornaiuolo G, Amato G, Gaeta GB, Caporaso N, Carella C. Clin Endocrinol (Oxf). 2003 Feb;58(2):207-12.
• Is the IFN-alpha-related thyroid autoimmunity an immunologically heterogeneous disease? Mazziotti G., Sorvillo F., Carbone A., Cioffi M., Morisco F., Carella C. J Intern Med. 2002 Oct; 252(4):377-8.
• Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis: a prospective study. Mazziotti G, Sorvillo F, Morisco F, Carbone A, Rotondi M, Stornaiuolo G; Precone DF, Gaeta GB, Caporaso N, Carella C. Cancer, 2002 Dec 15, 95(12):2539-45.
• Tomato based functional food as Interferon adjuvant in HCV eradication therapy. Filomena Morisco, Paola Vitaglione, Antonella Carbone, Nicola Caporaso. J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S118-20.
• Use of carotenoid-based functional foods minimizes the severity of ribavirin induced anemia in patients with chronic hepatitis C: a randomized study. Filomena Morisco, Antonella Carbone, Vincenzo Fogliano, Nicola Caporaso Gastroenterology Apr 2003
• Measure of oxidative stress in patient with chronic hepatitis C undergoing antiviral treatment. Filomena Morisco, Antonio Ascione, Antonella Carbone [...] Nicola Caporaso. Digest Liver Dis Jun 2002
• Comparison of thyroid autoantibody pattern and disfunction in patients with chronic hepatitis C during interferon or interferon plus ribavirin therapy. Filomena Morisco, Gherardo Mazziotti, Mario Rotondi, Michele Cioffi, Concetta Tuccillo, Francesca Sorvillo, Antonella Carbone, [...] Nicola Caporaso Digest Liver Dis Jun 2002

• Corso di formazione manageriale per direttore di struttura complessa (ALTEMS 2021)
• I Corso Itinerante di Ecografia in Endocrinologia: Tiroide e Paratiroidi, tenutosi a Napoli 1l 18 novembre 1998;
• “Corso di formazione avanzata: alimentazione e salute” tenutosi a Firenze dal 9 al 12 ottobre 2002;
• “Ospedale senza Dolore” tenutosi presso il PO di Ariano Irpino nel 2005;
• “Management Sanitario”, tenutosi presso la sede dell’ASL AV/1 in via Cardito, Ariano Irpino (AV) nel 2005.

• Corso di formazione manageriale per direttore di struttura complessa, ALTEMS, 2021
• I Corso Itinerante di Ecografia in Endocrinologia: Tiroide e Paratiroidi, Napoli, 1998-11-18
• Corso di formazione avanzata: alimentazione e salute, Firenze, 2002-10-09, 2002-10-12
• Ospedale senza Dolore, PO di Ariano Irpino, 2005
• Management Sanitario, ASL AV/1 in via Cardito, Ariano Irpino (AV), 2005

• Papillary thyroid carcinoma as first and isolated neoplastic disease in a Lynch syndrome family member with a germline MLH1 mutation., Verrienti A, Carbone A, Sponziello M, Pecce V, Cito DS, Bruno R, Endocrine, 2022-06-01, 77, 1, 199-202, 10.1007/s12020-022-03048-1, 35415788
• Long-term disease recurrence in the adipose tissue and striated muscles of a minimally invasive papillary thyroid carcinoma., Verrienti A, Carbone A, Cito DS, Sponziello M, Pecce V, Bruno R, Endocrine, 2021-06-01, 72, 3, 937-939, 10.1007/s12020-020-02558-0, 33275186
• Mediastinal lymph node metastases 6 years after latero-cervical lymph node dissection for metastases from undiagnosed occult papillary thyroid carcinoma., Antonella Carbone, Domenico Savio Cito, Pasquale Bellitti, Maria Chiara Fabiano, Rocco Bruno, Endocrine, 2020-07-01
• Desmoid tumor after total thyroidectomy and radioiodine therapy for papillary thyroid carcinoma., Antonella Carbone, Domenico Savio Cito, Pasquale Bellitti, Maria Chiara Fabiano, Rocco Bruno, International Journal of Medical Science and Health Research, 2019-01-01, 3, 06
• Papillary thyroid microcarcinoma: active surveillance in the follow-up of persistence structural disease., Pasquale Bellitti, Antonella Carbone, Domenico Savio Cito, Rocco Bruno, Haematology and Medical Oncology, 2018-01-01, 3, 2, 1-1
• Papillary carcinoma in struma ovarii., Carbone A, Lagonigro G., Bruno R., Journal Endocrinol Investigation, 2017-06-01, 40, 6, 687-688
• Genotype-Phenotype correlation in a MODY2 family: an under-diagnosed disease., Fabiano M.C., Verrienti A., Carbone A., Sponziello M., Bellitti P., Bruno R., Journal of Diabetes Mellitus, 2016-01-01, 6, 263-268
• A novel double mutation val 648ile and val804leu of RET protoncogene in multiple endocrine neoplasia type2., Verrienti A., Carbone A., Bellitti P., Fabiano M.C., De Rose RF, Maranghi M., Lucia P., Durante C., Rosignolo F., Pecce V., Sponziello M., Puppin C., Costante G., Bruno R., Endocrine Pract., 2015-11-01, 21, 11, 1248-54
• Hashimoto's encefalopathy (HE): an underdiagnosed autoimmune-mediated encephalopathy., Carbone A., Amenduni T., Bruno R., Endocrine, 2015-12-09, 10.1007/s12020-015-0806-4
• Precocious and isolated thyroid metastasis of colorectal adenocarcinoma and incidental thyroid papillary microcarcinoma., Amenduni T., Carbone A., Bruno R., Endocrine, 2014-12-01, 47, 3, 969-970
• Lymph node metastasis from undiagnosed occult papillary thyroid cancer., Carbone A., Bellitti P., Bruno R., Endocrine, 2014-04-01, 45, 3, 504-5
• A case of anaplastic diffuse large B-cell thyroid lymphoma: unique immunophenotype and unusual clinical presentation., Bruno R., Giannasio P., Bellitti P., Carbone A., Poggiaspalla M., Russo D., Costante G., J Endocrinol Investi, 2010-11-01, 33, 10, 767-8
• Unusual association of Hashimoto's thyroiditis autoimmune hepatitis., Amenduni T., Bellitti P., Carbone A., De Sanctis D., Santospirito EV, Coluccci R, Minnaja G., Bruno R., Thyroid, 2007-12-01, 17, 12, 1307-8
• Human thyrotropin reduces serum vascular endothelial growth factor levels in patients monitored for thyroid carcinoma even in the absence of thyroid tissue., Sorvillo F, Mazziotti G, Carbone A, Piscopo M, Rotondi M, Cioffi M, Musto P, Biondi B, Iorio S, Amato G, Carella C., J Clin Endocrinol Metab., 2003-10-01, 88, 10, 4818-22
• Grey-scale analysis allows a quantitative evaluation of thyroid echogenicity in patients with Hashimoto's thyroiditis., Mazziotti G, Sorvillo F, Iorio S, Carbone A, Romeo A, Piscopo M, Capuano S, Capuano E, Amato G, Carella C, Clin Endocrinol (Oxf)., 2003-08-01, 59, 2, 223-9
• Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis., Sorvillo F, Mazziotti G, Carbone A, Morisco F, Cioffi M, Rotondi M, Stornaiuolo G, Amato G, Gaeta GB, Caporaso N, Carella C., Clin Endocrinol (Oxf)., 2003-02-01, 58, 2, 207-12
• Is the IFN-alpha-related thyroid autoimmunity an immunologically heterogeneous disease?, Mazziotti G., Sorvillo F., Carbone A., Cioffi M., Morisco F., Carella C., J Intern Med., 2002-10-01, 252, 4, 377-8
• Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus related cirrhosis: a prospective study., Mazziotti G, Sorvillo F, Morisco F, Carbone A, Rotondi M, Stornaiuolo G, Precone DF, Gaeta GB, Caporaso N, Carella C., Cancer, 2002-12-15, 95, 12, 2539-45
• Tomato based functional food as Interferon adjuvant in HCV eradication therapy., Filomena Morisco, Paola Vitaglione, Antonella Carbone, Nicola Caporaso, J Clin Gastroenterol., 2004-07-01, 38, 6 Suppl, S118-20, 10.1097/01.mcg.0000128935.48082.f9, 15220675
• Use of carotenoid-based functional foods minimizes the severity of ribavirin induced anemia in patients with chronic hepatitis C: a randomized study., Filomena Morisco, Antonella Carbone, Vincenzo Fogliano, Nicola Caporaso, Gastroenterology, 2003-04-01
• Measure of oxidative stress in patient with chronic hepatitis C undergoing antiviral treatment., Filomena Morisco, Antonio Ascione, Antonella Carbone, Nicola Caporaso, Digest Liver Dis, 2002-06-01
• Comparison of thyroid autoantibody pattern and dysfunction in patients with chronic hepatitis C during interferon or interferon plus ribavirin therapy., Filomena Morisco, Gherardo Mazziotti, Mario Rotondi, Michele Cioffi, Concetta Tuccillo, Francesca Sorvillo, Antonella Carbone, Nicola Caporaso, Digest Liver Dis, 2002-06-01

• iscritta all’Associazione Medici Endocrinologi (AME)
• iscritta all’Associazione ItalianaDonne Medico (AIDM) sez.Matera
• partecipante all’Italian Thyroid Carcinoma Observatory (ITCO) per la provincia di Matera
• Iscritta alla European Endocrine Society (ESE)
• associata Fidapa-BPW